KV PHARMACEUTICAL CO /DE/·4

Jan 15, 6:02 PM ET

KANTERMAN RONALD J 4

4 · KV PHARMACEUTICAL CO /DE/ · Filed Jan 15, 2009

Insider Transaction Report

Form 4
Period: 2009-01-13
KANTERMAN RONALD J
DirectorVP, CFO & Treasurer
Transactions
  • Award

    Option to Purchase

    2009-01-13+50,00050,000 total
    Exercise: $2.95Exp: 2019-01-13Class A Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The option vests in three installments: 33% on January 13, 2010, 33% on January 13, 2011 and 34% on January 13, 2012.

Documents

2 files
  • 4
    doc1.xmlPrimary

    FORM 4

  • EX-24.1

    POWER OF ATTORNEY